Adherence to Desvenlafaxine Versus Usual Care and Its Impact on Health Outcomes: A Comparative Real-world Clinical Study

ConclusionsDesvenlafaxine is significantly associated with a higher adherence rate at 12 months compared to usual care based on SSRI or other SNRI. This suggests that desvenlafaxine could improve disease management having a positive impact on disease-associated costs.

http://link.springer.com/10.1007/s40261-021-01086-7

Source: Clinical Drug Investigation - November 6, 2021 Category: Drugs & Pharmacology Source Type: research